MENU
+Compare
BIOX
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$4.35
Change
+$0.12 (+2.84%)
Capitalization
764.39M

BIOX Bioceres Crop Solutions Corp Forecast, Technical & Fundamental Analysis

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers... Show more

BIOX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BIOX with price predictions
Apr 23, 2025

BIOX saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for BIOX moved out of overbought territory on April 16, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 55 similar instances where the indicator exited the overbought zone. In of the 55 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIOX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BIOX entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on BIOX as a result. In of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BIOX just turned positive on April 11, 2025. Looking at past instances where BIOX's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BIOX advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

BIOX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.543) is normal, around the industry mean (3.524). P/E Ratio (36.047) is within average values for comparable stocks, (22.688). BIOX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.575). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (1.771) is also within normal values, averaging (681.478).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BIOX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIOX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
BIOX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BIOX is expected to report earnings to fall 784.21% to -6 cents per share on May 08

Bioceres Crop Solutions Corp BIOX Stock Earnings Reports
Q1'25
Est.
$-0.06
Q4'24
Missed
by $0.17
Q3'24
Missed
by $0.08
Q2'24
Missed
by $0.26
Q1'24
Missed
by $0.03
The last earnings report on February 11 showed earnings per share of 0 cents, missing the estimate of 18 cents. With 64.39K shares outstanding, the current market capitalization sits at 764.39M.
A.I. Advisor
published General Information

General Information

a manager of investments in agricultural biotechnology

Industry ChemicalsAgricultural

Profile
Fundamentals
Details
Industry
Financial Conglomerates
Address
Ocampo 210 Bis
Phone
+54 3414861100
Employees
790
Web
https://www.biocerescrops.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VTMFX42.84N/A
N/A
Vanguard Tax-Managed Balanced Adm
PIEFX15.79N/A
N/A
Federated Hermes Emerging Markets Eq IS
FSAGX35.89N/A
N/A
Fidelity Select Gold
NSCAX43.25N/A
N/A
Nuveen Small-Cap Value Opps A
TAVZX58.42N/A
N/A
Third Avenue Value Z

BIOX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BIOX has been loosely correlated with MOS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BIOX jumps, then MOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOX
1D Price
Change %
BIOX100%
-1.17%
MOS - BIOX
34%
Loosely correlated
+0.32%
CTVA - BIOX
33%
Poorly correlated
+0.69%
NTR - BIOX
29%
Poorly correlated
-0.73%
SMG - BIOX
27%
Poorly correlated
+0.94%
FMC - BIOX
27%
Poorly correlated
-0.05%
More